The compound has substantial cosmetic-ingredient regulated use in topical preparations under the relevant cosmetic regulatory frameworks, distinct from any pharmaceutical approval
Originally studied for gastric protection, BPC-157 shows multi-organ cytoprotection and inflammation control, which may translate to less edema and improved healing conditions
Centrally, such mapping [59,70], i.e., L-NAME non-responsive, L-arginine-responsive provides that counteraction by BPC 157 of the cognitive dysfunction, novel object recognition test, as a particular resembling negative-like symptom fully corresponds to the counteracting of the resembling positive-like symptoms (acute apomorphine-, chronic methamphetamine-, acute MK-801-induced effects and acute haloperidol-induced catalepsy) [59,70]
You can read consumer alerts on the agencys Consumer Advice page